← All Lists
supplements · 11 items · 1 min read

11 Supplement Myths That Menopausal Women Keep Believing (And What the Evidence Actually Shows)

Rose
A note from Rose

The number of times women in perimenopause spend serious money on supplements recommended in Facebook groups, only to feel quietly disappointed when nothing changes — it's heartbreaking and completely unnecessary. The gap between what's marketed to menopausal women and what's actually studied is enormous, and closing that gap is exactly why this page exists.

Learn more about Rose →
The menopause supplement market is worth billions, and the misinformation circulating in online communities, wellness spaces, and even doctor's waiting rooms can make it nearly impossible to know what's worth trying and what's quietly draining the bank account. Some widely trusted supplements have surprisingly weak evidence; others that get dismissed actually have real data behind them. Here's what the research genuinely shows — no brand loyalty, no agenda.
1

Myth: Black Cohosh Balances Your Hormones

Black cohosh does not contain phytoestrogens and does not raise or 'balance' estrogen levels — this is a persistent and demonstrably false claim. What the evidence actually shows is more modest: some women report reduced hot flash frequency, but multiple large RCTs, including the NIH-funded HALT study, found no significant benefit over placebo for vasomotor symptoms. Its mechanism remains poorly understood, and it carries a rare but real risk of hepatotoxicity that warrants caution.

Grade A — Strong evidence
2

Myth: Magnesium Is Only Good for Sleep

Magnesium is consistently undersold as a sleep aid and dramatically oversold as a cure-all, when the truth is more interesting than either framing. Magnesium glycinate and magnesium threonate have decent evidence for improving sleep latency and quality in peri- and postmenopausal women, likely because declining estrogen disrupts magnesium metabolism and GABA signaling simultaneously. Beyond sleep, magnesium also plays a meaningful role in mood regulation, bone metabolism, and reducing migraine frequency — all relevant concerns during the menopause transition.

Grade B — Moderate evidence
3

Myth: Soy Supplements Are Dangerous for Women with Breast Cancer History

The fear that dietary soy or soy isoflavone supplements fuel estrogen-receptor-positive breast cancer is widespread in menopause communities but is not supported by current evidence. Soy isoflavones are phytoestrogens, meaning they bind estrogen receptors weakly and can actually act as partial antagonists in breast tissue — a fundamentally different mechanism to endogenous estrogen. Major cancer organisations including the American Cancer Society have reviewed the data and do not advise women with breast cancer history to avoid moderate soy consumption, though high-dose isolated isoflavone supplements in this group remain an area where individual oncologist guidance is wise.

Grade B — Moderate evidence
4

Myth: Vitamin D Supplements Will Prevent Bone Loss on Their Own

Vitamin D is essential for calcium absorption and bone metabolism, and genuine deficiency — extremely common in menopausal women — absolutely warrants correction. However, the idea that taking vitamin D alone prevents osteoporosis or fractures is not supported by the evidence: multiple large trials, including the VITAL study, found vitamin D supplementation alone did not significantly reduce fracture risk in non-deficient populations. Vitamin D works as part of a system that requires adequate calcium intake, weight-bearing exercise, and — most powerfully — estrogen, which is the primary driver of bone loss during menopause.

Grade A — Strong evidence
5

Myth: Evening Primrose Oil Relieves Hot Flashes

Evening primrose oil is one of the most widely recommended supplements in menopause forums for hot flashes, but the clinical evidence is genuinely thin. The few RCTs that exist show no statistically significant reduction in hot flash frequency or severity compared to placebo. It contains gamma-linolenic acid, which has anti-inflammatory properties, but there is no established physiological pathway by which this reliably addresses vasomotor symptoms driven by hypothalamic thermoregulatory changes.

Grade B — Moderate evidence
6

Myth: More Collagen Powder Means Better Skin During Menopause

Collagen supplements have attracted genuine research interest, and the picture is more nuanced than either enthusiasts or dismissers suggest. Hydrolysed collagen peptides at doses of 2.5–10g daily do have emerging evidence for improving skin elasticity and hydration, with several small but well-designed RCTs showing modest benefits. The bigger truth is that the primary driver of skin thinning during menopause is estrogen loss, which reduces dermal collagen by approximately 30% in the first five years — no supplement comes close to addressing that root cause the way HRT does.

Grade B — Moderate evidence
7

Myth: Maca Root Is a Proven Menopause Treatment

Maca is a Peruvian root vegetable that has developed a devoted following in menopause communities, promoted heavily for everything from libido to hot flashes to mood. The evidence base consists almost entirely of small, short-duration trials with significant methodological limitations — no large RCTs exist, and results are inconsistent across studies. It appears to have no estrogenic activity, so any benefits reported are likely mediated through adrenal or central nervous system pathways that remain speculative; it is probably harmless for most women, but calling it a proven treatment is a significant overreach.

Grade C — Emerging/anecdotal
8

Myth: You Can Get Enough Omega-3 from Flaxseed Alone

Flaxseed is high in ALA (alpha-linolenic acid), a plant-based omega-3, but the human body converts ALA to the biologically active forms EPA and DHA at an efficiency rate of only around 5–10% — and this conversion may be even less efficient in postmenopausal women. The cardiovascular and anti-inflammatory benefits associated with omega-3 fatty acids in the research literature are linked specifically to EPA and DHA, not ALA. Women relying on flaxseed as their sole omega-3 source are likely not achieving the tissue levels needed to influence inflammation, mood, or cardiovascular risk in any meaningful way.

Grade A — Strong evidence
9

Myth: Progesterone Cream Is a Safe, Natural Alternative to HRT

Over-the-counter progesterone creams are marketed aggressively as 'bioidentical' and 'natural' alternatives to prescribed HRT, but the evidence against their effectiveness is clear and important. Topical progesterone from creams is absorbed erratically and does not reliably achieve serum or uterine levels sufficient to protect the endometrium — which is the critical function progesterone must perform in any woman with a uterus taking estrogen. Women using progesterone cream as their sole progestogen while on estrogen therapy may have an unprotected uterus without knowing it; this is not a fringe concern but a documented finding in clinical studies.

Grade B — Moderate evidence
10

Myth: High-Dose B12 Improves Menopause Brain Fog

Brain fog during perimenopause is real, distressing, and physiologically driven primarily by fluctuating estrogen affecting neurotransmitter systems and hippocampal function. B12 deficiency — which does become more common with age due to reduced stomach acid affecting absorption — can independently cause cognitive symptoms, and correcting a genuine deficiency is genuinely worthwhile. However, the widespread practice of taking high-dose B12 supplements without testing for deficiency first means most women already have adequate B12, and supplementing further has no demonstrated effect on menopause-related cognitive changes.

Grade B — Moderate evidence
11

Myth: Ashwagandha Is Proven to Lower Menopause-Related Cortisol and Anxiety

Ashwagandha (Withania somnifera) has a growing evidence base as an adaptogen, and it is not without merit — several RCTs in stressed adults show modest reductions in self-reported stress, cortisol levels, and anxiety scores. However, nearly all of the studies use heterogeneous populations, different extract formulations, and short durations, and very few have been conducted specifically in perimenopausal or postmenopausal women. It also interacts with thyroid hormone pathways — relevant because thyroid dysfunction becomes significantly more common during the menopause transition — meaning it warrants more caution than its 'natural' branding typically suggests.

Grade C — Emerging/anecdotal

Want to go deeper?

Rose covers every symptom, supplement, and condition in full detail — evidence-graded and agenda-free.

Rose
Meet Rose

Rose is a free, evidence-based reference built for women navigating perimenopause and menopause. No ads. No products to sell. No agenda. Just honest answers — because every woman in this season deserves a trusted friend who has done the research.

Sharing is caring 💕 If this list helped you feel a little less alone, consider passing Rose along to a friend who might need honest answers too.